Zoetis Inc. (ZTS) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Group 1 - The company reported a strong fiscal year 2025 with a 6% growth in revenue on an organic operational basis [2] - The bottom line also showed a 7% increase year-over-year, indicating strong financial discipline throughout the profit and loss statement [2] - The growth was characterized by a tale of two halves, with the first half achieving 9% growth, while the second half saw a decline to 6% due to various factors [2] Group 2 - There was noted weakness in the U.S. consumer market, which impacted overall performance [3]